CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01335230
NCT01335230N/ACompleted
CompareCT.gov

Exploring the Role of Gut-associated TH17 in Microbial Translocation in HIV and HCV/HIV Co-infected Patients

University of Cincinnati·observational·Posted Apr 14, 2011·Updated Sep 11, 2015

In Brief

An observational study for HIV and 2 related conditions. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The purpose of this research study is to explore what role immune cells within the gut (the sigmoid colon) have locally and on the immune system of patients infected with HCV, HIV or HCV/ HIV co-infection.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV, Hepatitis C, Chronic, HCV Coinfection
CountriesUnited States
CollaboratorsMerck Sharp & Dohme LLC

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 14, 2011
Enrollment StartApr 1, 2011
Primary CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 15.2 years ago